A detailed history of Washington Trust Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Washington Trust Bank holds 14,122 shares of ABBV stock, worth $2.54 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
14,122
Previous 14,400 1.93%
Holding current value
$2.54 Million
Previous $2.47 Million 12.92%
% of portfolio
0.27%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $45,547 - $55,413
-278 Reduced 1.93%
14,122 $2.79 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $72,751 - $84,957
-470 Reduced 3.16%
14,400 $2.47 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $1.22 Million - $1.4 Million
-7,663 Reduced 34.01%
14,870 $2.71 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $10,732 - $12,087
-78 Reduced 0.34%
22,533 $3.49 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $855,777 - $990,687
6,406 Added 39.53%
22,611 $3.37 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $95,274 - $118,563
-719 Reduced 4.25%
16,205 $2.18 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $91,104 - $104,920
-630 Reduced 3.59%
16,924 $2.7 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $46,057 - $55,234
333 Added 1.93%
17,554 $2.84 Million
Q3 2022

Nov 15, 2022

SELL
$134.21 - $153.93 $119,581 - $137,151
-891 Reduced 4.92%
17,221 $2.31 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $143,812 - $182,833
-1,045 Reduced 5.45%
18,112 $2.77 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $739,219 - $917,163
-5,601 Reduced 22.62%
19,157 $3.11 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $353,766 - $447,617
-3,293 Reduced 11.74%
24,758 $3.35 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $302,176 - $343,015
-2,840 Reduced 9.19%
28,051 $3.03 Million
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $108,050 - $120,374
-1,027 Reduced 3.22%
30,891 $3.48 Million
Q1 2021

Apr 22, 2021

SELL
$102.3 - $112.62 $8.78 Million - $9.66 Million
-85,795 Reduced 72.88%
31,918 $3.45 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $114,295 - $154,311
1,420 Added 1.22%
117,713 $12.6 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $222,420 - $261,048
-2,589 Reduced 2.18%
116,293 $10.2 Million
Q2 2020

Jul 29, 2020

BUY
$73.37 - $98.18 $5,429 - $7,265
74 Added 0.06%
118,882 $11.7 Million
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $367,456 - $557,109
5,697 Added 5.04%
118,808 $9.05 Million
Q4 2019

Jan 29, 2020

SELL
$72.13 - $90.25 $166,476 - $208,297
-2,308 Reduced 2.0%
113,111 $10 Million
Q3 2019

Oct 29, 2019

BUY
$62.98 - $75.72 $255,572 - $307,271
4,058 Added 3.64%
115,419 $8.74 Million
Q2 2019

Jul 26, 2019

BUY
$65.7 - $83.98 $84,950 - $108,586
1,293 Added 1.17%
111,361 $8.1 Million
Q1 2019

Apr 09, 2019

BUY
$77.14 - $90.79 $707,836 - $833,089
9,176 Added 9.09%
110,068 $8.87 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $1,790 - $2,208
23 Added 0.02%
100,892 $9.3 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $475,935 - $529,090
-5,353 Reduced 5.04%
100,869 $9.54 Million
Q2 2018

Jul 03, 2018

SELL
$89.78 - $106.23 $179,919 - $212,884
-2,004 Reduced 1.85%
106,222 $9.84 Million
Q1 2018

Apr 03, 2018

SELL
$92.01 - $123.21 $854,588 - $1.14 Million
-9,288 Reduced 7.9%
108,226 $10.2 Million
Q4 2017

Jan 03, 2018

SELL
$89.56 - $98.21 $86,246 - $94,576
-963 Reduced 0.81%
117,514 $11.4 Million
Q3 2017

Oct 05, 2017

BUY
$69.85 - $89.22 $8.28 Million - $10.6 Million
118,477
118,477 $10.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Washington Trust Bank Portfolio

Follow Washington Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Bank with notifications on news.